South India led India's bioeconomy, contributing 45.4% ($75.2 billion), with Maharashtra, Karnataka, and Telangana emerging ...

In a bid to combat the circulation of inferior pharmaceutical products in Nigeria, Emzor Pharmaceutical Industry has ...

In attempt to keep R&D costs low, the vivarium business model has emerged as a crucial solution for drug developers.

AstraZeneca has announced a $2.5bn investment to establish the company’s sixth worldwide strategic R&D centre in China.

Emzor Pharmaceuticals has announced plans to boost local drug production and improve the availability and affordability ...

Despite promising charts, Bertie finds little growth in India’s pharmaceutical sales and faces hurdles in installing an ...

A U.S. court has ordered the state of Maryland to release data on horseshoe crab deaths in the state in response to a lawsuit ...

Health care supplier provides special answers to special problems through diverse inventory and full-spectrum manufacturing services.

Indian generics saved the US healthcare system $219 billion in 2022 and $1.3 trillion between 2013 and 2022, IQVIA has said ...

Integrated research campuses offer a structured, multi-stakeholder environment where knowledge generation, commercialisation, ...

With Eli Lilly’s Mounjaro entering India, the weight-loss drug race is on. But with steep prices and generics on the way, how ...

The UK’s life sciences sector is missing out on £15bn annually due to declining global competitiveness, falling exports and ...